Trial intelligence / Profile preview

Human coagulation factor VIII for hemophilia A

CTR20171490Phase 3Completed

Sponsor
Hualan Biological Engineering Chongqing
Start
Feb 2018
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of antihemophilic factor human in hemophilia A, sponsored by Hualan Biological Engineering Chongqing. Started Feb 2018; status: completed.

02

Drugs

antihemophilic factor human
03

Conditions

hemophilia A

Beyond the preview

Go deeper on CTR20171490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20171490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call